美国疾控中心数据显示:2025年美国药物过量死亡人数连续第三年下降


2026年5月13日 美国东部时间下午2:04 / 路透社

一张标牌坐落于美国佐治亚州亚特兰大市疾控中心罗亚尔园区外,2026年3月18日摄。路透社/梅根·瓦纳/档案照片 购买授权使用

5月13日(路透社)——美国联邦政府周三发布的估算数据显示,2025年美国药物过量死亡人数下降了近14%,这是该数据连续第三年出现下滑。

以下是详细信息:

用《每日案卷》新闻简报发送的最新法律新闻开启你的早晨。点击此处订阅。

  • 据美国疾控中心的临时数据显示,2025年美国约有69973人死于药物过量,而一年前的估算死亡人数为81313人。
  • 专家表示,被称为纳洛酮的强效过量解毒药物的广泛普及,是死亡人数下降的重要原因。
  • 疾控中心的估算数据显示,涉及阿片类药物的死亡人数从一年前的55296人降至2025年的约44564人。
  • 包括芬太尼在内的合成阿片类药物,仍是美国药物过量死亡的单一最大诱因。
  • 报告称,尽管美国大多数州的药物过量死亡人数均出现下降,但新墨西哥州、亚利桑那州和科罗拉多州的死亡人数较2024年同期增长了10%以上。

马里亚姆·桑尼在班加罗尔报道;沙伊莱什·库伯编辑

我们的准则:路透社信任原则。

US drug overdose deaths dropped for third straight year in 2025, CDC data shows

May 13, 2026 2:04 PM UTC / Reuters

A sign sits outside the Centers for Disease Control and Prevention (CDC) Roybal campus in Atlanta, Georgia, U.S. March 18, 2026. REUTERS/Megan Varner/File Photo Purchase Licensing Rights

May 13 (Reuters) – Drug overdose deaths in the United States fell nearly 14% in ​2025, federal estimates showed on ‌Wednesday, marking a third consecutive year of declines.

Here are some details:

Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.

  • Nearly 69,973 people died ​from drug overdose in the ​U.S. in 2025, compared with 81,313 ⁠deaths estimated a year earlier, according ​to provisional data from the U.S. ​Centers for Disease Control and Prevention.
  • The wide availability of a medication called naloxone, a potent ​overdose antidote, has significantly contributed ​to the drop, according to experts.
  • Deaths involving opioids ‌fell ⁠to an estimated 44,564 in 2025 from 55,296 a year earlier, the CDC estimates showed.
  • Synthetic opioids, including Fentanyl, ​are the ​single largest ⁠contributor to overdose deaths in the country.
  • While most states ​across the nation showed declines ​in ⁠overdose deaths, New Mexico, Arizona and Colorado had increases of 10% or ⁠more ​compared to the same ​period in 2024, the report said.

Reporting by Mariam ​Sunny in Bengaluru; Editing by Shailesh Kuber

Our Standards: The Thomson Reuters Trust Principles.

评论

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注